Several NAFL patient cohorts have revealed the upregulation of APOA4 expression in the steatotic liver [66] during the early stages of liver fibrosis [67] and elevated plasma levels of APOA4 among [9] NAFL patients. The gene discussed is APOA4; the disease is Hepatic fibrosis.